Black Diamond Therapeutics shows promise with BDTX-1535 for NSCLC treatment. Click here to find out why I rate BDTX stock a ...

Precision Medicine Online readers were interested in stories about implementation challenges in the space, the first cell therapies for solid tumors, and cardiovascular drugs targeting Lp(a).

Sentinal4D, a spinout company from The Institute of Cancer Research, London, has been announced to the public – having closed its first round of funding and appointed its foundational leadership team.

Ryan Nguyen, DO, physician and researcher at the University of Illinois Chicago, emphasizes the transformative impact of immunotherapy in non–small cell lung cancer (NSCLC) and the need for precise ...

Foghorn Therapeutics ( (FHTX) ) has provided an announcement. Foghorn Therapeutics has unveiled its strategic roadmap, ...

A 2022 analysis of over 38,000 patients with advanced non-small cell lung cancer (NSCLC) revealed alarming gaps in precision oncology implementation. This study found that: The above stumbling ...

as an ordinary resolution, THAT the appointment of Ernst & Young Hua Ming LLP as auditor of the Company for the fiscal year ending December 31, 2024 be ratified and that the directors of the Company ...

University of North Carolina at Chapel Hill will establish a new Cancer Identification and Precision Oncology Center with an up to $10 million grant from the Advanced Research Projects Agency for ...

When the Precision Medicine Initiative was launched in 2015, it completely transformed patient care in oncology. Now, ...

AI-driven tools for prescreening patients, predicting responses and outcomes, and guiding patient therapy are maturing and entering the market.

COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics COTA Inc., a leader in real-world data (RWD ...

Miami Cancer Institute, part of Baptist Health South Florida, announced its third annual Precision Oncology Symposium, which will be held Feb. 7-8, 2025, at Loews Coral Gables Hotel in Florida.